Adlai Nortye Group Ltd. (ANL) News
Follow Adlai Nortye Group Ltd. (ANL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. NASDAQ:ANL (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innovativ
NEWS | Sep 30, 2026, 11:08 AM UTC
L
Jefferies initiates Adlai Nortye Group buy at $31 price target
Jefferies initiated coverage on Adlai Nortye Group with a Buy rating and a $31.00/share price target, according to TradingView News via Benzinga.
EQUITY | Sep 10, 2026, 12:30 PM UTC
L
HC Wainwright maintains Adlai Nortye $20 price target
HC Wainwright & Co. maintained its $20.00/share price target on Adlai Nortye, according to ratings actions reported by Benzinga via TradingView News.
EQUITY | Sep 08, 2026, 04:07 PM UTC
L
ANL price target set to $49 by Lucid Capital Markets
Lucid Capital Markets announced a $49.00/share price target for ANL, according to Benzinga ratings actions.
EQUITY | Sep 08, 2026, 12:17 PM UTC
M
Adlai Nortye announces first dose and FDA IND clearance for AN4035
Adlai Nortye said it dosed its first patient in Australia and received U.S. FDA IND clearance for AN4035, a pan-RAS(ON) inhibitor-based ADC.
REGULATION | Sep 08, 2026, 11:01 AM UTC
H
Adlai Nortye (ANL) reports unaudited first-half 2026 results
Adlai Nortye Ltd. (ANL) reports unaudited financial results and highlights for the first half of 2026, alongside recent operational progress.
EQUITY | Aug 14, 2026, 11:00 AM UTC
M
Australia: Adlai Nortye Starts Phase I Trial
Adlai Nortye begins Phase I trial for AN4035
EQUITY | Aug 03, 2026, 11:00 AM UTC